Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Pfizer has submitted the unaudited financial results for the quarter ended June 30, 2022, which were approved by the Board of Directors of the Company at its Meeting held today, that commenced at 12:00 noon and concluded at 2:45 pm. The company has enclosed the Limited Review Report by our Auditors Walker Chandiok & Co LLP, in respect of the above results.
The above information is a part of company’s filings submitted to BSE.
